ArticleRheumatology (Oxford, England)2022

Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection.

Jérôme Avouac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.